Breaking News Instant updates and real-time market news.

MRNA

Moderna

$20.15

1.76 (9.57%)

10:56
01/10/20
01/10
10:56
01/10/20
10:56

Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital

After Moderna reported additional Phase 1 data for its CMV mRNA vaccine, Roth Capital analyst Yasmeen Rahimi contended that the company is "inching closer to a blockbuster CMV vaccine" as the second interim readout confirms clean safety for mRNA-1647 with the neutralizing mAbs higher after a third dose. The analyst, who thinks interim safety and immunogenicity data due in the second half of this year can "serve as the green light for strategic interest in other mRNA vaccines," keeps a Buy rating on Moderna shares with a $24 price target.

  • 10

    Jan

  • 13

    Jan

MRNA Moderna
$20.15

1.76 (9.57%)

08/16/19
PIPR
08/16/19
NO CHANGE
Target $30
PIPR
Overweight
Moderna should be bought ahead of catalysts, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends buying shares of Moderna on weakness ahead of the company's R&D day on September 12. Moderna has completed enrollment of the Phase I study of cytomegalovirus vaccine mRNA-1647 with data soon, and the company could also report preliminary Phase I data on intratumoral mRNA-2754 by the end of 2019, Tenthoff tells investors in a research note. Further, the analyst is focused on the Phase I chikungunya antibody mRNA-1944 data in Q4 for read-through to Moderna's orphan disease pipeline. He sees multiple clinical data readouts through the end of the year and reiterates an Overweight rating on the shares with a $30 price target.
09/13/19
PIPR
09/13/19
NO CHANGE
Target $32
PIPR
Overweight
Moderna price target raised to $32 from $30 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Moderna to $32 from $30 after the company presented interim Phase I data on mRNA-1944 showing dose-dependent functional Chikingunya antibody production. These data have important read-through to Moderna's orphan disease pipeline, Tenthoff tells investors in a research note. He believes the company's pipeline is advancing and reiterates an Overweight rating on the shares.
10/25/19
ROTH
10/25/19
INITIATION
Target $24
ROTH
Buy
Moderna initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi initiated coverage of Moderna with a Buy rating and $24 price target. She believes the company is well funded to bring its 16 clinical programs to the next inflection point and sees a buying opportunity ahead of upcoming milestones, Rahimi tells investors. Investors, who "are challenged to find the needle in the haystack when it comes to picking the winning mRNA candidates from the 21 programs in development," continue to sit on the sidelines despite the company's continued clinical and preclinical progress, Rahimi added.
12/03/19
BOFA
12/03/19
INITIATION
Target $29
BOFA
Buy
Moderna resumed with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham resumed coverage of Moderna with a Buy rating and $29 price target. The analyst cites the company's phase 1 pipeline readouts having achieved a proof of concept with a "modified mRNA approach", showcasing "good tolerability, antigen-specific immune responses, and functional protein production." Meacham believes that Moderna's platform should de-risk further in 2020, with data-to-date supporting its potential to have broad therapeutic utility.

TODAY'S FREE FLY STORIES

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Hot Stocks
First Bancshares raises quarterly dividend to 10c from 8c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Earnings
First Bancshares reports Q4 EPS 72c, consensus 74c »

Reports Q4 NII $33.8M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNVC

NanoViricides

$8.10

4.76 (142.51%)

20:39
01/21/20
01/21
20:39
01/21/20
20:39
Syndicate
NanoViricides 2.5M share Secondary priced at $3.00 »

Aegis is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$89.76

0.76 (0.85%)

, BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

20:25
01/21/20
01/21
20:25
01/21/20
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$89.76

0.76 (0.85%)

BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

ALLY

Ally Financial

$30.25

-0.19 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Mar

MDT

Medtronic

$120.30

1.32 (1.11%)

20:03
01/21/20
01/21
20:03
01/21/20
20:03
Recommendations
Medtronic analyst commentary at Piper Sandler »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 18

    Feb

CNC

Centene

$65.48

0.96 (1.49%)

, WCG

WellCare

$340.52

3.55 (1.05%)

19:49
01/21/20
01/21
19:49
01/21/20
19:49
Hot Stocks
WellCare, Centene satisfy merger requirements »

Centene (CNC) and…

CNC

Centene

$65.48

0.96 (1.49%)

WCG

WellCare

$340.52

3.55 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 13

    Feb

AAPL

Apple

$316.39

-2.27 (-0.71%)

, HNHPF

Hon Hai Precision

$0.00

(0.00%)

19:17
01/21/20
01/21
19:17
01/21/20
19:17
Periodicals
Apple suppliers to start making new low-cost iPhone in February, Bloomberg says »

Apple (AAPL) suppliers…

AAPL

Apple

$316.39

-2.27 (-0.71%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

EFC

Ellington Financial

$18.85

0.13 (0.69%)

19:12
01/21/20
01/21
19:12
01/21/20
19:12
Syndicate
Ellington Financial 4.6M share Spot Secondary priced at $18.29 »

Morgan Stanley, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

MRVSY

Minerva SA

$0.00

(0.00%)

18:59
01/21/20
01/21
18:59
01/21/20
18:59
Downgrade
Minerva SA rating change at Goldman Sachs »

Minerva SA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:57
01/21/20
01/21
18:57
01/21/20
18:57
Downgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCU

Compania Cervecerias

$19.00

-0.33 (-1.71%)

18:53
01/21/20
01/21
18:53
01/21/20
18:53
Downgrade
Compania Cervecerias rating change at Goldman Sachs »

Compania Cervecerias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:50
01/21/20
01/21
18:50
01/21/20
18:50
Upgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPAGF

Gruma

$0.00

(0.00%)

18:48
01/21/20
01/21
18:48
01/21/20
18:48
Upgrade
Gruma rating change at Goldman Sachs »

Gruma upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOF

Coca-Cola Femsa

$62.52

0.41 (0.66%)

18:47
01/21/20
01/21
18:47
01/21/20
18:47
Upgrade
Coca-Cola Femsa rating change at Goldman Sachs »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$47.77

1.2 (2.58%)

18:46
01/21/20
01/21
18:46
01/21/20
18:46
Hot Stocks
Logitech CEO: We're growing all three of our businesses at a healthy clip »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

NAVI

Navient

$13.86

-0.01 (-0.07%)

, IBM

IBM

$139.15

0.84 (0.61%)

18:44
01/21/20
01/21
18:44
01/21/20
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NAVI

Navient

$13.86

-0.01 (-0.07%)

IBM

IBM

$139.15

0.84 (0.61%)

COF

Capital One

$102.29

-1.85 (-1.78%)

FBK

FB Financial

$38.20

-0.66 (-1.70%)

NFLX

Netflix

$338.24

-1.32 (-0.39%)

MNLO

Menlo Therapeutics

$6.48

-0.17 (-2.56%)

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

ETN

Eaton

$94.51

-1.19 (-1.24%)

SUPN

Supernus

$24.70

0.26 (1.06%)

ZION

Zions Bancorp

$49.93

-0.81 (-1.60%)

IBKR

Interactive Brokers

$50.89

0.7 (1.39%)

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

FULT

Fulton Financial

$17.26

-0.07 (-0.40%)

UAL

United Airlines

$85.84

-3.84 (-4.28%)

ADAP

Adaptimmune

$4.14

-0.38 (-8.41%)

BPMC

Blueprint Medicines

$79.69

-1.46 (-1.80%)

ELAN

Elanco

$30.64

0.65 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 28

    Jan

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

  • 14

    Feb

  • 19

    Feb

  • 26

    Feb

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

SUPN

Supernus

$24.70

0.26 (1.06%)

18:35
01/21/20
01/21
18:35
01/21/20
18:35
Hot Stocks
Supernus: FDA accepts for review NDA for SPN-812 »

Supernus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:31
01/21/20
01/21
18:31
01/21/20
18:31
Hot Stocks
Netflix says doesn't want to 'exploit' users with advertising »

Says mobile-only plans in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

COST

Costco

$313.28

8.6 (2.82%)

18:25
01/21/20
01/21
18:25
01/21/20
18:25
Hot Stocks
Costco CEO: We're a volume company, not a margin company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:24
01/21/20
01/21
18:24
01/21/20
18:24
Hot Stocks
Netflix says plans to increase content spending across the board »

Says plans to increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PBR

Petrobras

$14.76

-0.41 (-2.70%)

18:23
01/21/20
01/21
18:23
01/21/20
18:23
Hot Stocks
Petrobras says CARF issued 'unfavorable' decision on tax proceeding »

Petrobras said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBI

First Midwest

$21.58

-0.725 (-3.25%)

18:15
01/21/20
01/21
18:15
01/21/20
18:15
Earnings
First Midwest reports Q4 EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:14
01/21/20
01/21
18:14
01/21/20
18:14
Hot Stocks
Netflix says Oscar-nominated original films 'very popular' with users as well »

Netflix (NFLX) says…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 04

    Feb

MDT

Medtronic

$120.30

1.32 (1.11%)

18:12
01/21/20
01/21
18:12
01/21/20
18:12
Hot Stocks
Medtronic: Trial shows 'superior' back pain relief with DTM SCS »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:07
01/21/20
01/21
18:07
01/21/20
18:07
Hot Stocks
Netflix says seasonality from Q1 to Q2 likely to be 'more balanced' »

Netflix (NFLX) says Q1…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

GOOG

Alphabet

$1,484.92

4.64 (0.31%)

GOOGL

Alphabet Class A

$1,482.70

3.58 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.